Why is there no cure for cancer? Because the medical industry doesn't want one! And the pharmaceutical industry doesn't want one! Because they would lose too much money!

In this quote, Genesis P-Orridge suggests a controversial view on the ongoing search for a cure for cancer. P-Orridge claims that the medical industry and the pharmaceutical industry have little incentive to find a cure because of the potential loss of profits from the current treatment methods. The quote reflects a conspiracy theory mindset, asserting that the enormous financial interests tied to cancer treatment—such as chemotherapy, radiation, and medication—create a financial ecosystem that would be disrupted by a definitive cure.

P-Orridge’s statement taps into a broader criticism of the profit-driven nature of modern medicine. He implies that rather than focusing solely on curing diseases, these industries may prioritize ongoing treatments that keep patients coming back for longer periods. The quote is an expression of skepticism towards the medical system, suggesting that profit motives might undermine the pursuit of truly effective treatments or cures.

The idea that industries are more interested in money than human well-being is a recurring theme in critiques of the healthcare and pharmaceutical sectors. P-Orridge seems to be channeling this frustration, arguing that the business aspect of medicine can overshadow the true goal of finding solutions to health problems. His bold stance invites listeners to question whether the incentives driving the healthcare system are genuinely aligned with the needs of patients.

Ultimately, Genesis P-Orridge’s quote challenges the public to think critically about the relationship between corporate interests and healthcare. While the claim is contentious and highly debated, it draws attention to the potential conflict between the pursuit of scientific advancement and the financial stakes involved in medical treatments. The quote serves as a provocative commentary on the complexities and ethical dilemmas within the medical industry.